Tata Motors, Orchid Chemicals, Sesa Sterlite in Focus Today
- Orchid Chemicals & Pharmaceuticals got USFDA approval for Eszopiclone tablet. The drug is used for treating insomnia.
- United Phosphorus sold its entire 50 per cent stake in Brazilian agrochemical company in a move to deleverage its balance sheet.
- Indian Hotels is considering a Rs 1,000 crore CCD (Compulsorily Convertible Debenture) rights offer. Its board is meeting on June 24 to consider the ratio, pricing, tenor and coupon of the issue.
- Tata Motors: Jaguar Land Rover will launch Discover Sports SUV in 2015. The company will invest 200 million pound in Halewood unit which will manufacture Discover Sport SUV.
- Sesa Sterlite may react positively today as the government has initiated valuation of Balco for stake sale. Sesa Sterlite, which holds 51 per cent stake in Balco, is eying the remaining 49 per cent stake in Balco.
- Atul Auto will consider stock split on June 26.
- Maruti Suzuki India: UBS maintains buy on the stock with a target price at Rs 3,000 per share. The brokerage says Maruti has strong new product cycle with 5 launches. It expects 27 per cent CAGR growth in earnings of the company over FY14-17.
- Tata Power Company: Citi has downgraded Tata Power to sell from buy. The brokerage says the stock is expensive even in an optimistic scenario. Even if tariff hike is taken into account the stock looks expensive, added Citi. Citi advised investors to switch to CESC.
- ONGC & Oil India: CLSA has given buy recommendation on ONGC and Oil India. The brokerage expects subsidies to fall to a historical low and also it expects the government to implement oil & gas reforms.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
